FIREFLY NEUROSCIENCE, INC. quarterly report, Q1 FY2018

Business context and reporting period

Entity discrepancy: The request identifies Firefly Neuroscience, Inc., but the supplied Form 10-Q is filed by Information Analysis Incorporated (IAI), a Virginia-based IT services and software company. This summary reflects the supplied filing, not a Firefly filing.

The report covers the three months ended March 31, 2018, compared with the three months ended March 31, 2017. IAI provides IT modernization, software, and professional services, with substantial exposure to U.S. federal government contracts.

Financial results and liquidity

MetricQ1 2018Q1 2017 or comparison
Revenue$1,394,476$1,481,648; down 5.9%
Gross profit / margin$550,421 / 39.5%$499,845 / 33.7%
Operating loss$35,947$33,574
Net loss$33,276$31,616
Operating cash flow$(493,539)$(131,318)
Cash and cash equivalents$2,236,937 at March 31, 2018$2,731,510 at December 31, 2017
Total assets / liabilities$3,162,979 / $1,295,942$3,734,983 / $1,840,958 at December 31, 2017

Investing cash outflow was $1,034, resulting in a $494,573 net decrease in cash. The company reported no interest paid and no income tax paid in the quarter. No amounts were drawn on its $1 million revolving credit line; no other debt balance is reported in the supplied filing. Basic and diluted loss per share are displayed as “$-”; the filing text does not provide a clear nonzero per-share value.

Material changes versus the prior comparable period

  • Professional-fee revenue rose 19.0% to $1,213,647, primarily due to a new federal-procurement subcontract.
  • Software revenue fell 60.8% to $180,829, reflecting the non-recurring and variable nature of software sales.
  • Gross margin improved to 39.5% from 33.7%. Professional-fee gross margin declined to 44.6% from 47.6%, while software gross margin increased to 5.2% from 3.2%.
  • SG&A expense increased 12.3% to $470,494, attributed to overhead labor and benefits, ISO certification, state business costs, and stock options. Commission expense was $115,874, versus $114,633.
  • Net loss increased slightly to $33,276 from $31,616. Operating cash use increased materially year over year, with working-capital movements including lower accrued liabilities and contract liabilities.

Outlook, risks, and unusual items

  • Management said cash and the operating plan should meet cash requirements for at least 12 months from the filing date. The $1 million credit line expires May 31, 2018; renewal on similar terms was expected, not confirmed in this filing.
  • Management reported no material capital-expenditure commitments and no off-balance-sheet arrangements. The company stated disclosure controls were effective and reported no material change in internal control over financial reporting.
  • Revenue concentration is significant: in Q1 2018, one subcontract generated 38.3% of revenue and one prime contract generated 23.6%. One federal subcontract represented 51.6% of accounts receivable; one prime contract represented 16.8%.
  • Federal prime contracts and subcontracts together generated 93.3% of Q1 2018 revenue. Risks identified include federal funding and procurement changes, competition, technology changes, contract cost or timing estimates, and dependence on subcontractors and third-party software suppliers.
  • The company adopted ASC 606 on January 1, 2018; it reported no material impact on quarterly financial statements or opening equity. It had $15.0 million of federal net operating loss carryforwards, including $7.8 million that would expire unused on December 31, 2018.
  • The filing reports no legal proceedings and no material changes to the risk factors in the 2017 Form 10-K. Software sales and margins were described as subject to considerable period-to-period fluctuation.

Important facts for investors to verify

  • Confirm the intended issuer: the supplied filing is for Information Analysis Incorporated, not Firefly Neuroscience, Inc.
  • Verify renewal and terms of the revolving credit line that was due to expire May 31, 2018.
  • Assess the sustainability of operating cash use and the effect of working-capital changes on cash balances.
  • Review contract and receivable concentration, particularly the subcontract representing 38.3% of quarterly revenue and 51.6% of receivables.
  • Check the status and usability of the $7.8 million of net operating loss carryforwards scheduled to expire in 2018.